Bio-Techne Corporation Cash Conversion Cycle 2011-2026 | TECH

Annual Cash Conversion Cycle Bio-Techne Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
197	207	192	158	155	175	184	185	160	150	148	156	179	192	270

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
270	148	181

Quarterly Cash Conversion Cycle Bio-Techne Corporation

2025-Q4	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
210	218	-	207	204	200	-	204	215	221	-	200	193	177	85.8	155	151	146	71.4	154	151	164	149	160	168	171	175	168	169	181	163	164	155	188	133	164	189	169	136	140	161	158	137	145	147	136	116	116	162	158	144	149	186	193	191	199	208	222	230	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
230	71.4	168

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Xeris Pharmaceuticals XERS	535	$ 6.03	-1.55 %	$ 885 M	USA
I-Mab IMAB	-1.97 K	-	-	$ 866 M	China
UroGen Pharma Ltd. URGN	127	$ 19.2	-11.52 %	$ 554 M	Israel
uniQure N.V. QURE	-1.34 K	$ 10.89	-30.36 %	$ 530 M	Niderland
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
AbCellera Biologics ABCL	173	$ 3.74	3.6 %	$ 1.12 B	Canada
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Acorda Therapeutics ACOR	117	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Aeterna Zentaris AEZS	-34.3 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	-8.96 K	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Agenus AGEN	-6 K	$ 3.36	0.86 %	$ 1.2 M	USA
Ayala Pharmaceuticals AYLA	-2.15 K	-	-	$ 7.46 M	Israel
Agios Pharmaceuticals AGIO	735	$ 29.16	-3.54 %	$ 1.69 B	USA
Advaxis ADXS	-143 K	-	-9.65 %	$ 45.9 M	USA
Завод ДИОД DIOD	-32.7	-	-	-	Russia
Фармсинтез LIFE	-15.9	-	-	-	Russia
Albireo Pharma ALBO	-1.55 K	-	-0.23 %	$ 916 M	USA
Alector ALEC	-13.8	$ 2.19	-9.77 %	$ 226 M	USA
Altimmune ALT	15.1 K	$ 4.21	-2.32 %	$ 299 M	USA
Teligent, Inc. TLGT	120	-	-13.85 %	$ 16.1 M	USA
Evogene Ltd. EVGN	-32.5	$ 0.84	-4.24 %	$ 27.9 M	Israel
Viela Bio, Inc. VIE	139	-	-	$ 2.91 B	USA
Ampio Pharmaceuticals AMPE	-2.85 K	-	-11.43 %	$ 502 K	USA
Amarin Corporation plc AMRN	213	$ 13.98	1.27 %	$ 5.7 B	Irlanda
AbbVie ABBV	284	$ 233.57	0.64 %	$ 413 B	USA
Blueprint Medicines Corporation BPMC	254	-	-	$ 8.14 B	USA
AIM ImmunoTech AIM	46	$ 0.8	-11.6 %	$ 38.5 M	USA
Aptorum Group Limited APM	-400	$ 0.83	5.37 %	$ 4.53 M	China
Apellis Pharmaceuticals APLS	115	$ 20.67	-1.38 %	$ 2.61 B	USA